Bcl3 gene expression is increased in ovarian clear-cell adenocarcinoma, ovarian endometrioid adenocarcinoma, ovarian mucinous adenocarcinoma, ovarian serous adenocarcinoma, and ovarian serous surface papillary carcinoma [47]. Here, BCL3 is linked to ovarian mucinous adenocarcinoma.